$QWTR
Quest Water Global, Inc.

2023 Q1 Form 10-Q Financial Statement

#000149315223018558 Filed on May 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development $922.00 $963.00
YoY Change -4.26%
% of Gross Profit
Depreciation & Amortization $125.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $142.4K $144.6K
YoY Change -1.54%
Operating Profit -$144.6K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$142.4K -$144.6K
YoY Change -1.54%
Income Tax
% Of Pretax Income
Net Earnings -$144.6K -$144.6K
YoY Change 0.0% 75.2%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00
COMMON SHARES
Basic Shares Outstanding 131.9M shares 85.16M shares
Diluted Shares Outstanding 131.9M shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $4.170K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $7.870K
Receivables
Other Receivables
Total Short-Term Assets $7.870K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.042K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $1.042K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $7.870K
Total Long-Term Assets $1.042K
Total Assets $8.912K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $1.426M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$11.42M
YoY Change
Common Stock $132.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.418M -$3.815M
YoY Change
Total Liabilities & Shareholders Equity $8.912K
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$144.6K -$144.6K
YoY Change 0.0% 75.2%
Depreciation, Depletion And Amortization $125.00 $0.00
YoY Change
Cash From Operating Activities -$57.00
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $140.1K
YoY Change
NET CHANGE
Cash From Operating Activities -$57.00
Cash From Investing Activities
Cash From Financing Activities $140.1K
Net Change In Cash -$57.00
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$57.00
Capital Expenditures
Free Cash Flow $0.00
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001487091
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
usd
CY2022Q1 us-gaap Depreciation
Depreciation
usd
CY2023Q1 QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
333-168895
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
QUEST WATER GLOBAL, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1994359
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Suite 209 – 828 Harbourside Drive
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
North Vancouver
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2023Q1 dei Entity Address Country
EntityAddressCountry
CA
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V7P 3R9
CY2023Q1 dei City Area Code
CityAreaCode
(888)
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
897-5536
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
131903029 shares
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7870 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1094 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
7870 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1094 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1042 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1167 usd
CY2023Q1 us-gaap Assets
Assets
8912 usd
CY2022Q4 us-gaap Assets
Assets
2261 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
46684 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
37698 usd
CY2023Q1 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
36200 usd
CY2022Q4 QWTR Investment In Partnership Current
InvestmentInPartnershipCurrent
33980 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1426414 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1275132 usd
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.000001
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
2 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
2 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
1 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131903029 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
132 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10000348 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11417983 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11273352 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1417502 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1272871 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8912 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2261 usd
CY2023Q1 QWTR Automotive Expenses
AutomotiveExpenses
2459 usd
CY2022Q1 QWTR Automotive Expenses
AutomotiveExpenses
2645 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
125 usd
CY2023Q1 us-gaap Management Fee Expense
ManagementFeeExpense
123750 usd
CY2022Q1 us-gaap Management Fee Expense
ManagementFeeExpense
112500 usd
CY2023Q1 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
1943 usd
CY2022Q1 QWTR Office And Miscellaneous Expense
OfficeAndMiscellaneousExpense
1690 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
2969 usd
CY2022Q1 us-gaap Professional Fees
ProfessionalFees
13781 usd
CY2023Q1 QWTR Rent
Rent
5485 usd
CY2022Q1 QWTR Rent
Rent
5250 usd
CY2023Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
922 usd
CY2022Q1 us-gaap Communications And Information Technology
CommunicationsAndInformationTechnology
963 usd
CY2023Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
4758 usd
CY2022Q1 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
7806 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
142411 usd
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
144635 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-142411 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-144635 usd
CY2023Q1 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
2220 usd
CY2022Q1 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
7716 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-144631 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-152351 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.001
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.002
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85164569 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1272871 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-144631 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-1417502 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3728198 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-152351 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-3880549 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-144631 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-152351 usd
CY2023Q1 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
2220 usd
CY2022Q1 QWTR Decrease In Equity Of Investment
DecreaseInEquityOfInvestment
7716 usd
CY2023Q1 us-gaap Depreciation
Depreciation
125 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
6776 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
10123 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8987 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-46 usd
CY2022Q1 QWTR Increase Decrease In Due To Related Company
IncreaseDecreaseInDueToRelatedCompany
-7958 usd
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
140075 usd
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
162705 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-57 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4227 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4170 usd
CY2023Q1 QWTR Working Capital Deficiency
WorkingCapitalDeficiency
1418544 usd
CY2023Q1 QWTR Liability To Principal Stockholders Due To Working Capital Deficiency
LiabilityToPrincipalStockholdersDueToWorkingCapitalDeficiency
1293689 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-11417983 usd
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.10
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2200000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.10
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6300000 shares
CY2023Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
2220 usd
CY2022Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
7716 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1500 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
458 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1042 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6300000 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.10
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
95000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.000001
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131903029 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85164569 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
144631 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
152351 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
131903029 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
85164569 shares
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6300000 shares
CY2023Q1 QWTR Issued And Outstanding Common Stock Percentage
IssuedAndOutstandingCommonStockPercentage
0.10 pure
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
8500000 shares
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.10
CY2023Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y3M14D

Files In Submission

Name View Source Status
0001493152-23-018558-index-headers.html Edgar Link pending
0001493152-23-018558-index.html Edgar Link pending
0001493152-23-018558.txt Edgar Link pending
0001493152-23-018558-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
qwtr-20230331.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
qwtr-20230331_cal.xml Edgar Link unprocessable
qwtr-20230331_def.xml Edgar Link unprocessable
qwtr-20230331_lab.xml Edgar Link unprocessable
qwtr-20230331_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable